Epileptiform activity and cognitive deficits in SNAP-25+/- mice are normalized by antiepileptic drugs

Cerebral Cortex

Volumn 24, Issue 2, 2014, Pages 364-376

  Corradini, Irene ^a,c   Donzelli, Andrea ^a   Antonucci, Flavia ^a,b   Welzl, Hans ^c   Loos, Maarten ^d,e   Martucci, Roberta ^a   De Astis, Silvia ^a,b   Pattini, Linda ^f   Inverardi, Francesca ^g   Wolfer, David ^d   Caleo, Matteo ^b   Bozzi, Yuri ^b,j   Verderio, Claudia ^b   Frassoni, Carolina ^g   Braida, Daniela ^a   Clerici, Mario ^h   Lipp, Hans Peter ^d   Sala, Mariaelvina ^a   Matteoli, Michela ^a,i  

^a UNIVERSITY OF MILAN   (Italy)

^b CNR   (Italy)

^c Fondazione Filarete   (Italy)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e Sylics Synaptologics BV   (Netherlands)

^f POLITECNICO DI MILANO   (Italy)

^g DEPARTMENT OF NEUROSURGERY   (Italy)

^h IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

ⁱ HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^j UNIVERSITY OF TRENTO   (Italy)

more..

Author keywords

Epilepsy; Memory; SNAP 25; Valproate

Indexed keywords

CARBAMAZEPINE; ETHOSUXIMIDE; KAINIC ACID; NIMODIPINE; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; VALPROIC ACID;

ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT THERAPY; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; ELECTROENCEPHALOGRAPHY; EPILEPTIC DISCHARGE; EXPERIMENTAL BEHAVIORAL TEST; GENOTYPE; HABITUATION; HETEROZYGOTE; HYPERACTIVITY; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LEARNING DISORDER; MALE; MEMORY DISORDER; MOTOR ACTIVITY; MOUSE; NERVE CELL DEGENERATION; NERVE CELL EXCITABILITY; NERVE CELL NETWORK; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEIZURE; SPIKE WAVE; STATE DEPENDENT LEARNING;

EPILEPSY; MEMORY; SNAP-25; VALPROATE;

ANIMALS; ANTICONVULSANTS; ASSOCIATION LEARNING; BRAIN; CARBAMAZEPINE; COGNITION DISORDERS; EPILEPSY; ETHOSUXIMIDE; HYPERKINESIS; KAINIC ACID; MALE; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONS; NIMODIPINE; SEIZURES; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25; VALPROIC ACID;

EID: 84896369293     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhs316     Document Type: Article

References (67)

1. Aarts JHP, Binnie CD, Smit AM, Wilkins AJ. 1984. Selective cognitive impairment during focal and generalised epileptiform EEG activity. Brain. 107:293-308.
2. Aldenkamp AP, Arends J, de la Parra NM, Migchelbrink EJ. 2010. The cognitive impact of epileptiform EEG discharges and short epileptic seizures: relationship to characteristics of the cognitive tasks. Epilepsy Behav. 17:205-209.
3. Aldenkamp AP, Beitler J, Arends J, van der Linden I, Diepman L. 2005. Acute effects of subclinical epileptiform EEG discharges on cognitive activation. Funct Neurol. 20:23-28.
4. Antonucci F, Di Garbo A, Novelli E, Manno I, Sartucci F, Bozzi Y, Caleo M et al. 2008. Botulinum neurotoxin E (BoNT/E) reduces CA1 neuron loss and granule cell dispersion, with no effects on chronic seizures, in a mouse model of temporal lobe epilepsy. Exp Neurol. 210:388-401.
5. Atlas D. 2001. Functional and physical coupling of voltage-sensitive calcium channels with exocytotic proteins: ramifications for the secretion mechanism. J Neurochem. 77:972-985.
6. Barnes KA, Howard JH Jr, Howard DV, Kenealy L, Vaidya CJ. 2010. Two forms of implicit learning in childhood ADHD. Dev Neuropsychol. 35:494-505.
7. Barr CL, Feng Y, Wigg K, Bloom S, Roberts W, Malone M, Schachar R, Tannock R, Kennedy JL. 2000. Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit hyperactivity disorder. Mol Psychiatry. 5:405-409.
8. Becker K, Sinzig JK, Holtmann M. 2004. Attention deficits and subclinical epileptiform discharges: are EEG diagnostics in ADHD optional or essential? Dev Med Child Neurol. 46:501-502.
9. Bozzi Y, Vallone D, Borrelli . 2000. Neuroprotective role of dopamine against hippocampal cell death. J Neurosci. 20:8643-8649.
10. Brinciotti M, Matricardi M, Paolella A, Porro G, Benedetti P. 1989. Neuropsychological correlates of subclinical paroxysmal EEG activity in children with epilepsy: qualitative features (generalized and focal abnormalities). Funct Neurol. 4:235-239.
11. Bruno KJ, Freet CS, Twining RC, Egami K, Grigson PS, Hess EJ. 2007. Abnormal latent inhibition and impulsivity in coloboma mice, a model of ADHD. Neurobiol Dis. 25:206-216.
12. Catterall WA, Few AP. 2008. Calcium channel regulation and presynaptic plasticity. Neuron. 59:882-901.
13. Chang YT, Chen PC, Tsai IJ, Sung FC, Chin ZN, Kuo HT, Tsai CH, Chou IC. 2011. Bidirectional relation between schizophrenia and epilepsy: a population-based retrospective cohort study. Epilepsia. 52:2036-2042.
14. Choudhary S, Verma SK, Raheja G, Kaur P, Joshi K, Gill KD. 2006. The L-type calcium channel blocker nimodipine mitigates cytoskeletal proteins phosphorylation in dichlorvos-induced delayed neurotoxicity in rats. Basic Clin Pharmacol Toxicol. 98:447-455.
15. Chung WK, Shin M, Jaramillo TC, Leibel RL, LeDuc CA, Fischer SG, Tzilianos E, Gheith AA, Lewis AS, Chetkovich DM. 2009. Absence epilepsy in apathetic, a spontaneous mutant mouse lacking the h channel subunit, HCN2. Neurobiol Dis. 33:499-508.
16. Condliffe SB, Corradini I, Pozzi D, Verderio C, Matteoli M. 2010. Endogenous SNAP-25 regulates native voltage-gated calcium channels in glutamatergic neurons. J Biol Chem. 285:24968-24976.
17. Coulter DA. 1997. Antiepileptic drug cellular mechanisms of action: where does lamotrigine fit in? J Child Neurol. 12(Suppl. 1):S2-S9.
18. Davis SM, Katusic SK, Barbaresi WJ, Killian J, Weaver AL, Ottman R, Wirrell EC. 2010. Epilepsy in children with attention-deficit/hyperactivity disorder. Pediatr Neurol. 42:325-330.
19. DeLorey TM, Handforth A, Anagnostaras SG, Homanics GE, Minassian BA, Asatourian A, Fanselow MS, Delgado-Escueta A, Ellison GD, Olsen RW. 1998. Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. J Neurosci. 18:8505-8514.
20. Etain B, Dumaine A, Mathieu F, Chevalier F, Henry C, Kahn JP, Deshommes J, Bellivier F, Leboyer M, Jamain S. 2010. Snap25 promoter variant is associated with early-onset bipolar disorder and a high expression level in brain. Mol Psychiatry. 15:748-755.
21. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P. 2005. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry. 57:1313-1323.
22. Fatemi SH, Earle JA, Stary JM, Lee S, Sedgewick J. 2001. Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia. Neuroreport. 12:3257-3262.
23. Feng Y, Crosbie J, Wigg K, Pathare T, Ickowicz A, Schachar R, Tannock R, Roberts W, Malone M, Swanson J et al. 2005. The Snap25 gene as a susceptibility gene contributing to attention-deficit hyperactivity disorder. Mol Psychiatry. 10:998-1005.
24. Geddes JW, Hess EJ, Hart RA, Kesslak JP, Cotman CW, Wilson MC. 1990. Lesions of hippocampal circuitry define synaptosomalassociated protein-25 (SNAP-25) as a novel presynaptic marker. Neuroscience. 38:515-525.
25. Grant S. 2012. Synaptopathies: diseases of the synaptome. Curr Opin Neurobiol. 22:522-529.
26. Guerini FR, Bolognesi E, Chiappedi M, Manca S, Ghezzo A, Agliardi C, Sotgiu S, Usai S, Matteoli M, Clerici M. 2011. SNAP-25 single nucleotide polymorphisms are associated with hyperactivity in autism spectrum disorders. Pharmacol Res. 64:283-288.
27. Gunn RK, Keenan ME, Brown RE. 2011. Analysis of sensory, motor and cognitive functions of the coloboma (C3Sn.Cg-Cm/J) mutant mouse. Genes Brain Behav. 10:579-588.
28. Hess EJ, Collins KA, Wilson MC. 1996. Mouse model of hyperkinesis implicates SNAP-25 in behavioral regulation. J Neurosci. 16:3104-3111.
29. Hess EJ, Rogan PK, Domoto M, Tinker DE, Ladda RL, Ramer JC. 1995. Absence of linkage of apparently single gene mediated ADHD with the human syntenic region of the mouse mutant Coloboma. Am J Med Genet. 60:573-579.
30. Jahn R, Scheller RH. 2006. SNAREs-engines for membrane fusion. Nat Rev Mol Cell Biol. 7:631-643.
31. Johansson JU, Ericsson J, Janson J, Beraki S, Stanic D, Mandic SA, Wikström MA, Hökfelt T, Ogren SO, Rozell B 2008. An Ancient Duplication of Exon 5 in the Snap25 Gene Is Required for Complex Neuronal Development/Function. PloS Genet. 4:e1000278.
32. Kataoka M, Yamamori S, Suzuki E, Watanabe S, Sato T, Miyaoka H, Azuma S, Ikegami S, Kuwahara R, Suzuki-Migishima R et al. 2011. A single amino acid mutation in SNAP-25 induces anxiety-related behavior in mouse. PLoS One. 6:e25158.
33. Kustanovich V, Merriman B, McGough J, McCracken JT, Smalley SL, Nelson SF. 2003. Biased paternal transmission of SNAP-25 risk alleles in attention-deficit hyperactivity disorder. Mol Psychiatry. 8:309-315.
34. Laporte N, Sébire G, Gillerot Y, Guerrini R, Ghariani S. 2002. Cognitive epilepsy: ADHD related to focal EEG discharges. Pediatr Neurol. 27:307-311.
35. Larkin JG, Thompson GG, Scobie G, Forrest G, Drennan JE, Brodie MJ. 1992. Dihydropyridine calcium antagonists in mice: blood and brain pharmacokinetics and efficacy against pentylenetetrazol seizures. Epilepsia. 33:760-769.
36. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I, Williams NM, Schwab SG, Pulver AE, Faraone SV et al. 2003. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet. 73:34-48.
37. Liljelund P, Ferguson C, Homanics G, Olsen RW. 2005. Long-term effects of diazepam treatment of epileptic GABAA receptor beta3 subunit knockout mouse in early life. Epilepsy Res. 66:99-115.
38. Manfredi I, Zani AD, Rampoldi L, Pegorini S, Bernascone I, Moretti M, Gotti C, Croci L, Consalez GG, Ferini-Strambi L et al. 2009. Expression of mutant beta2 nicotinic receptors during development is crucial for epileptogenesis. Hum Mol Genet. 18:1075-1088.
39. Marrosu F, Bortolato M, Frau R, Orrù M, Puligheddu M, Fà M, Muroni A, Tuveri A, Mereu G. 2007. Levetiracetam attenuates spontaneous spike-and-wave discharges in DBA/2J mice. Epilepsy Res. 75:224-227.
40. Mikati MA, Holmes GL, Werner S, Bakkar N, Carmant L, Liu Z, Stafstrom CE. 2004. Effects of nimodipine on the behavioral sequalae of experimental status epilepticus in prepubescent rats. Epilepsy Behav. 5:168-174.
41. Mill J, Richards S, Knight J, Curran S, Taylor E, Asherson P. 2004. Haplotype analysis of SNAP-25 suggests a role in the aetiology of ADHD. Mol Psychiatry. 9:801-810.
42. Moroni RF, Inverardi F, Regondi MC, Panzica F, Spreafico R, Frassoni C. 2008. Altered spatial distribution of PV-cortical cells and dysmorphic neurons in the somatosensory cortex of BCNU-treated rat model of cortical dysplasia. Epilepsia. 49:872-887.
43. Mula M, Trimble MR. 2009. Antiepileptic drug-induced cognitive adverse effects: potential mechanisms and contributing factors. CNS Drugs. 23:121-137.
44. Nakazawa K, Sun LD, Quirk MC, Rondi-Reig L, Wilson MA, Tonegawa S. 2003. Hippocampal CA3 NMDA receptors are crucial for memory acquisition of one-time experience. Neuron. 38:305-315.
45. Oyler GA, Higgins GA, Hart RA, Battenberg E, Billingsley M, Bloom FE, Wilson MC. 1989. The identification of a novel synaptosomal associated protein, SNAP-25, differentially expressed by neuronal subpopulations. J Cell Biol. 109:3039-3052.
46. Parent JM, Yu TW, Leibowitz RT, Geschwind DH, Sloviter RS, Lowenstein DH. 1997. Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus. J Neurosci. 17:3727-3738.
47. Pozzi D, Condliffe S, Bozzi Y, Chikhladze M, Grumelli C, Proux-Gillardeaux V, Takahashi M, Franceschetti S, Verderio C, Matteoli M. 2008. Activity-dependent phosphorylation of Ser187 is required for SNAP-25-negative modulation of neuronal voltage-gated calcium channels. Proc Natl Acad Sci U S A. 105:323-328.
48. Richer LP, Shevell MI, Rosenblatt BR. 2002. Epileptiform abnormalities in children with attention-deficit-hyperactivity disorder. Pediatr Neurol. 26:125-129.
49. Rosenberg G. 2007. The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees? Cell Mol Life Sci. 64:2090-2103.
50. Russell VA. 2007. Neurobiology of animal models of attention-deficit hyperactivity disorder. J Neurosci Methods. 161:185-198.
51. Scarr E, Gray L, Keriakous D, Robinson PJ, Dean B. 2006. Increased levels of SNAP-25 and synaptophysin in the dorsolateral prefrontal cortex in bipolar I disorder. Bipolar Disord. 8:133-143.
52. Schauwecker PE, Steward O. 1997. Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches. Proc Natl Acad Sci U S A. 94:4103-4108.
53. Sgobio C, Ghiglieri V, Costa C, Bagetta V, Siliquini S, Barone I, Di Filippo M, Gardoni F, Gundelfinger ED, Di Luca M et al. 2010. Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment. Biol Psychiatry. 67:567-574.
54. Shitak R, Sahai AK, Hota D, Chakrabarti A. 2006. Anti-seizure efficacy of nimodipine in pentylenetetrazole and kainic acid combined seizure models in mice. Indian J Physiol Pharmacol. 50:265-272.
55. Südhof TC, Rothman JE. 2009. Membrane fusion: grappling with SNARE and SM proteins. Science. 323:474-477.
56. Thompson PM, Egbufoama S, Vawter MP. 2003. SNAP-25 reduction in the hippocampus of patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 27:411-417.
57. Thompson PM, Sower AC, Perrone-Bizzozero NI. 1998. Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia. Biol Psychiatry. 43:239-243.
58. Torrioli MG, Vernacotola S, Peruzzi L, Tabolacci E, Mila M, Militerni R, Musumeci S, Ramos FJ, Frontera M, Sorge G et al. 2008. A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys. Am J Med Genet A. 146:803-812.
59. Tripathi PP, Di Giovannantonio LG, Viegi A, Wurst W, Simeone A, Bozzi Y. 2008. Serotonin hyperinnervation abolishes seizure susceptibility in Otx2 conditional mutant mice. J Neurosci. 28:9271-9276.
60. van Praag H, Schinder AF, Christie BR, Toni N, Palmer TD, Gage FH. 2002. Functional neurogenesis in the adult hippocampus. Nature. 415:1030-1034.
61. Washbourne P, Thompson PM, Carta M, Costa ET, Mathews JR, Lopez-Benditó G, Molnár Z, Becher MW, Valenzuela CF, Partridge LD et al. 2001. Genetic ablation of the t-SNARE SNAP-25 distinguishes mechanisms of neuroexocytosis. Nat Neurosci. 5:19-26.
62. Wilson MC. 2000. Coloboma mouse mutant as an animal model of hyperkinesis and attention deficit hyperactivity disorder. Neurosci Biobehav Rev. 24:51-57.
63. Yoshida S, Okada M, Zhu G, Kaneko S. 2007. Carbamazepine prevents breakdown of neurotransmitter release induced by hyperactivation of ryanodine receptor. Neuropharmacology. 52:1538-1546.
64. Young CE, Arima K, Xie J, Hu L, Beach TG, Falkai P, Honer WG. 1998. SNAP-25 deficit and hippocampal connectivity in schizophrenia. Cereb Cortex. 8:261-268.
65. Zamponi GW. 2003. The L-type calcium channel C-terminus: sparking interest beyond its role in calcium-dependent inactivation. J Physiol. 552:333.
66. Zhang H, Zhu S, Zhu Y, Chen J, Zhang G, Chang H. 2010. An association study between SNAP-25 gene and attention-deficit hyperactivity disorder. Eur J Paediatr Neurol. 15:48-52.
67. Zhang Y, Vilaythong AP, Yoshor D, Noebels JL. 2004. Elevated thalamic low-voltage-activated currents precede the onset of absence epilepsy in the Snap25-deficient mouse mutant coloboma. J Neurosci. 24:5239-5248.